258 related articles for article (PubMed ID: 33629860)
41. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation.
Li C; Xi Y; Li S; Zhao Q; Cheng W; Wang Z; Zhong J; Niu X; Chen G
Mol Immunol; 2015 Oct; 67(2 Pt B):444-54. PubMed ID: 26224047
[TBL] [Abstract][Full Text] [Related]
42. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
Naeem M; Oshi MA; Kim J; Lee J; Cao J; Nurhasni H; Im E; Jung Y; Yoo JW
Nanomedicine; 2018 Apr; 14(3):823-834. PubMed ID: 29353017
[TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory efficacy of Berberine Nanomicelle for improvement of cerebral ischemia: formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model.
Azadi R; Mousavi SE; Kazemi NM; Yousefi-Manesh H; Rezayat SM; Jaafari MR
BMC Pharmacol Toxicol; 2021 Oct; 22(1):54. PubMed ID: 34600570
[TBL] [Abstract][Full Text] [Related]
44. Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis.
Yang C; Zhang M; Lama S; Wang L; Merlin D
J Control Release; 2020 Jul; 323():293-310. PubMed ID: 32335157
[TBL] [Abstract][Full Text] [Related]
45. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
[TBL] [Abstract][Full Text] [Related]
46. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
47. Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1/Th17 differentiation.
Regmi S; Pathak S; Nepal MR; Shrestha P; Park J; Kim JO; Yong CS; Choi DY; Chang JH; Jeong TC; Orive G; Yook S; Jeong JH
J Control Release; 2019 Dec; 316():138-149. PubMed ID: 31689461
[TBL] [Abstract][Full Text] [Related]
48. Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis.
Yan Y; Sun Y; Wang P; Zhang R; Huo C; Gao T; Song C; Xing J; Dong Y
Carbohydr Polym; 2020 Oct; 246():116660. PubMed ID: 32747292
[TBL] [Abstract][Full Text] [Related]
49. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
50. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model.
Melero A; Draheim C; Hansen S; Giner E; Carreras JJ; Talens-Visconti R; Garrigues TM; Peris JE; Recio MC; Giner R; Lehr CM
Eur J Pharm Biopharm; 2017 Oct; 119():361-371. PubMed ID: 28709903
[TBL] [Abstract][Full Text] [Related]
51. Spray-dried Solid Lipid Nanoparticles for Enhancing Berberine Bioavailability
Nguyen VH; Le KNM; Nguyen MCN
Curr Pharm Des; 2023; 29(38):3050-3059. PubMed ID: 37961862
[TBL] [Abstract][Full Text] [Related]
52. pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis.
Mahami S; Salehi M; Mehrabi M; Vahedi H; Hassani MS; Bitaraf FS; Omri A
Int J Biol Macromol; 2023 Jul; 244():125332. PubMed ID: 37302632
[TBL] [Abstract][Full Text] [Related]
53. Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis.
Lavi I; Levinson D; Peri I; Nimri L; Hadar Y; Schwartz B
Br J Nutr; 2010 Feb; 103(3):393-402. PubMed ID: 19772681
[TBL] [Abstract][Full Text] [Related]
54. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
Coco R; Plapied L; Pourcelle V; Jérôme C; Brayden DJ; Schneider YJ; Préat V
Int J Pharm; 2013 Jan; 440(1):3-12. PubMed ID: 22820482
[TBL] [Abstract][Full Text] [Related]
55. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
[TBL] [Abstract][Full Text] [Related]
56. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge.
Xu HY; Liu CS; Huang CL; Chen L; Zheng YR; Huang SH; Long XY
Colloids Surf B Biointerfaces; 2019 Sep; 181():927-934. PubMed ID: 31382342
[TBL] [Abstract][Full Text] [Related]
57. Osteopontin-loaded PLGA nanoparticles enhance the intestinal mucosal barrier and alleviate inflammation via the NF-κB signaling pathway.
Wei F; Lang Y; Shen Q; Xu L; Cheng N; Chu Y; Lyu H; Chen F
Colloids Surf B Biointerfaces; 2020 Jun; 190():110952. PubMed ID: 32172161
[TBL] [Abstract][Full Text] [Related]
58. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
59. Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice.
Zhao L; Du X; Tian J; Kang X; Li Y; Dai W; Li D; Zhang S; Li C
Front Pharmacol; 2021; 12():644387. PubMed ID: 33959013
[TBL] [Abstract][Full Text] [Related]
60. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
